Key result
CVD-related mortality among obese US adults rises significantly from 1999 to 2020 with notable demographic disparities.
Observational (n=26,410)
Yes
Cerebrovascular disease-related mortality among adults with obesity in the US has increased significantly from 1999 to 2020, with notable disparities across demographics and geography.
Answers are grounded in this paper and cite their sources.
May warrant targeted public health strategies addressing disparities in obese adults; challenges consensus on CVD mortality trends.
BACKGROUND: Cerebrovascular disease (CVD) remains a leading cause of death, with obesity exacerbating stroke risk through multiple metabolic pathways. However, long-term trends in CVD-related mortality among obese adults in the United States remain inadequately defined. METHODS: We analyzed national mortality data from 1999 to 2020 using the CDC WONDER database. Deaths were included if CVD (ICD-10 I60-I69) was the underlying cause and obesity (E66) a contributing cause. Age-adjusted mortality rates (AAMRs) were calculated, and temporal trends were evaluated using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). RESULTS: From 1999 to 2020, 26,410 CVD-related deaths occurred among obese adults. The overall AAMR was 0.53 per 100,000, with an AAPC of 4.59% (95% CI: 3.94 to 5.24). A statistically significant change in trend slope was observed after 2008, with accelerated mortality increases. Females had higher AAMRs (0.56) than males (0.49), though males experienced steeper increases (AAPC 5.98% vs. 3.64%). American Indian/Alaska Native and Black adults had the highest AAMRs (1.11 and 1.01, respectively). Mortality increased in all racial/ethnic groups, most rapidly among White individuals (AAPC 4.66%). Non-metropolitan areas showed higher mortality than metropolitan areas (0.71 vs. 0.50), with a widening urban-rural gap. Regionally, the West and Midwest had the highest AAMRs (0.59 and 0.57, respectively). Mortality rose across all age groups, with the steepest increases in younger adults aged 25-54 years. Most deaths occurred in hospitals (56%), followed by home (22.8%) and nursing facilities (15.7%). CONCLUSIONS: CVD-related mortality among obese adults has increased significantly since 1999, with substantial disparities across sex, race, geography, and age, highlighting the need for focused public health strategies.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) conducted an observational in Cerebrovascular disease and obesity (n=26,410). Time trend (1999-2020) was evaluated on Cerebrovascular disease-related mortality (Age-adjusted mortality rate and average annual percent change) (AAPC 4.59%, 95% CI 3.94 to 5.24). Cerebrovascular disease-related mortality among adults with obesity in the US increased from 1999 to 2020, with an average annual percent change of 4.59%.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: